Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan

Journal of Infection and Chemotherapy

Volumn 20, Issue 9, 2014, Pages 558-562

  Morii, Daiichi ^a   Seki, Masafumi ^a   Binongo, José N ^a   Ban, Ryoichi ^a   Kobayashi, Atsuko ^a   Sata, Makoto ^a   Hashimoto, Shigeki ^a   Shimizu, Junzo ^a   Morita, Shunji ^a   Tomono, Kazunori ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Candidemia; Distribution; Fluconazole susceptibility; Local epidemiology; Non albicans Candida

Indexed keywords

MICAFUNGIN; ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CHILD; COMORBIDITY; DEATH; FEMALE; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NEWBORN; NONHUMAN; TERTIARY CARE CENTER; VERY ELDERLY; BLOOD; CANDIDIASIS; CROSS INFECTION; DRUG EFFECTS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; YOUNG ADULT;

EID: 84929050318     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.05.009     Document Type: Article

References (26)

1. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 2004 309 317
2. L. Pagano, A. Antinori, A. Ammassari, L. Mele, A. Nosari, and L. Melillo et al. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes Eur J Haematol 63 1999 77 85
3. C. Viscoli, C. Girmenia, A. Marinus, L. Collette, P. Martino, and B. Vandercam et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC) Clin Infect Dis 28 1999 1071 1079
4. O.A. Cornely, M. Bassetti, T. Calandra, J. Garbino, B.J. Kullberg, and O. Lortholary et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients Clin Microbiol Infect 18 2012 19 37
5. Y. Taur, N. Cohen, S. Dubnow, A. Paskovaty, and S.K. Seo Effect of antifungal therapy timing on mortality in cancer patients with candidemia Antimicrob Agents Chemother 54 2010 184 190
6. M. Morrell, V.J. Fraser, and M.H. Kollef Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality Antimicrob Agents Chemother 49 2005 3640 3645
7. A.S. Kao, M.E. Brandt, W.R. Pruitt, L.A. Conn, B.A. Perkins, and D.S. Stephens et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance Clin Infect Dis 29 1999 1164 1170
8. M.A. Pfaller, and D.J. Diekema Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility J Clin Microbiol 40 2002 3551 3557
9. M. Drago, M.M. Scaltrito, and G. Morace In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei Eur J Clin Microbiol Infect Dis 23 2004 619 624
10. B.J. Spellberg, S.G. Filler, and J.E. Edwards Jr. Current treatment strategies for disseminated candidiasis Clin Infect Dis 42 2006 244 251
11. M.A. Pfaller, D.J. Diekema, R.N. Jones, H.S. Sader, A.C. Fluit, and R.J. Hollis et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program J Clin Microbiol 39 2001 3254 3259
12. A.L. Colombo, M. Nucci, B.J. Park, S.A. Nouér, B. Arthington-Skaggs, and D.A. da Matta et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers J Clin Microbiol 44 2006 2816 2823
13. P.G. Pappas, C.A. Kauffman, D. Andes, D.K. Benjamin Jr., T.F. Calandra, and J.E. Edwards Jr. et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America Clin Infect Dis 48 2009 503 535
14. R.A. Hajjeh, A.N. Sofair, L.H. Harrison, G.M. Lyon, B.A. Arthington-Skaggs, and S.A. Mirza et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program J Clin Microbiol 42 2004 1519 1527
15. D.J. Diekema, S.A. Messer, A.B. Brueggemann, S.L. Coffman, G.V. Doern, and L.A. Herwaldt et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study J Clin Microbiol 40 2002 1298 1302
16. M.A. Pfaller, D.J. Diekema, R.N. Jones, S.A. Messer, and R.J. Hollis Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000 J Clin Microbiol 40 2002 852 856
17. Y. Uehara, K. Makmura, K. Kamei, K. Suzuki, K. Kikuchi, and M. Niimi The current situation of severe fungal infection in Japan - a questionnaire based report Jpn J Antibiot 54 2001 448 472 [in Japanese]
18. A. Shimonaka, D. Morii, K. Tadera, J. Shimohana, and T. Michinaka Single center distribution of Candida species IRYO 65 2011 167 171 [in Japanese]
19. Y. Yamamoto, T. Mori, and T. Oguri Retrospective analysis of cases with fungemia detected in bloodstream and catheter cultures at Juntendo University Hospital Juntendo Igaku 28 2001 155 160 [in Japanese]
20. I. Kazama, and K. Furukawa A study of candidemia during the six years period from 1993 to 1999 in St. Luke's International Hospital Kansenshogaku Zasshi 77 2003 158 166 [in Japanese]
21. J. Garnacho-Montero, A. Díaz-Martín, E. García-Cabrera, M. Ruiz Pérez de Pipaón, C. Hernández-Caballero, and J. Aznar-Martín et al. Risk factors for fluconazole-resistant candidemia Antimicrob Agents Chemother 54 2010 3149 3154
22. R. Ben-Ami, K. Olshtain-Pops, M. Krieger, I. Oren, J. Bishara, and M. Dan et al. Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection Antimicrob Agents Chemother 56 2012 2518 2523
23. J. Dotis, P.A. Prasad, T. Zaoutis, and E. Roilides Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children Pediatr Infect Dis J 31 2012 557 560
24. A. Malani, J. Hmoud, L. Chiu, P.L. Carver, A. Bielaczyc, and C.A. Kauffman Candida glabrata fungemia: experience in a tertiary care center Clin Infect Dis 41 2005 975 981
25. A.N. Malani, G. Psarros, P.N. Malani, and C.A. Kauffman Is age a risk factor for Candida glabrata colonisation? Mycoses 54 2011 531 537
26. Y. Niki, and H. Mikamo Japanese guideline for invasive candidiasis 2012 The Japanese Society for Medical Mycology http://www.jsmm.org/pulic-comment2-1. pdf